vTv Therapeutics (VTVT) Free Cash Flow (2014 - 2026)
vTv Therapeutics (VTVT) reported Free Cash Flow of $9.2 million for Q1 2026, up 261.9% on a YoY basis from $2.5 million in Q1 2025, and up 199.21% sequentially from -$9.2 million in Q4 2025.
vTv Therapeutics (VTVT) Free Cash Flow (2014 - 2026) Analysis & Trends
vTv Therapeutics (VTVT) has 13 years of Free Cash Flow data on file, last reported at $9.2 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 261.9% year-over-year to $9.2 million; the trailing twelve-month figure through Mar 2026 stood at -$10.3 million (up 56.14% YoY), and the FY2025 full-year result was -$25.1 million, changed 0.23% from the prior year.
- Free Cash Flow grew to $9.2 million in Q1 2026, from -$9.2 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $9.2 million in Q1 2026 to a low of -$9.2 million in Q4 2025.
- A 5-year average of -$4.5 million and a median of -$5.2 million in 2025 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow slumped 973.51% in 2023 and surged 261.9% in 2026, its largest moves.
- Tracing VTVT's Free Cash Flow over 5 years: stood at -$6.9 million in 2022, then surged by 59.17% to -$2.8 million in 2023, then sank by 70.67% to -$4.8 million in 2024, then plunged by 92.47% to -$9.2 million in 2025, then soared by 199.21% to $9.2 million in 2026.
- Business Quant data shows VTVT's Free Cash Flow at $9.2 million in Q1 2026, -$9.2 million in Q4 2025, and -$5.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 158.09 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -354.95 Mn |
| 10 | vTv Therapeutics | 19.21 Mn | 19.21 Mn | - | 9.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.15 Mn |
| Mar 31, 2026 | 9.15 Mn |
| Dec 31, 2025 | -9.23 Mn |
| Dec 31, 2025 | -9.23 Mn |
| Sep 30, 2025 | -5.19 Mn |
| Sep 30, 2025 | -5.19 Mn |
| Jun 30, 2025 | -5.06 Mn |
| Jun 30, 2025 | -5.06 Mn |
| Mar 31, 2025 | -5.65 Mn |
| Mar 31, 2025 | -5.65 Mn |
| Dec 31, 2024 | -4.79 Mn |
| Dec 31, 2024 | -4.79 Mn |
| Sep 30, 2024 | -6.39 Mn |
| Sep 30, 2024 | -6.39 Mn |
| Jun 30, 2024 | -6.70 Mn |
| Jun 30, 2024 | -6.70 Mn |
| Mar 31, 2024 | -7.31 Mn |
| Mar 31, 2024 | -7.31 Mn |
| Dec 31, 2023 | -2.81 Mn |
| Dec 31, 2023 | -2.81 Mn |